Blog

The BioCentury China Healthcare Summit saw thought leaders from industry, academia and finance meet in Shanghai to learn about China’s burgeoning biopharma ecosystem. The nation has advances its biotech agenda, specifically targeting the sector in its industrial strategy, Made in China 2025. Like many countries, age-related diseases such as cancer are the main targets. Countries […]

read more

Headlines: CRISPR Ethics. Life Science Sector Deal Announced. CRISPR: Chinese research scientist, Dr He Jiankui, has claimed that twin girls born in November were genetically altered using CRISPR. If true, these are the first humans born with CRISPR-edited DNA that can be inherited by their children. The DNA coding for the CCR5 cell receptor, which […]

read more

UKI2S has privileged access to emerging research across many of the UK’s science and technology campuses. This access allows us to seek out and support innovative young companies through our unique source of patient capital funding, helping to bring in outside investment and guide young companies in various fields. One such laboratory is the Babraham […]

read more

1 2 3 4 5 26